Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Artificial nasolacrimal duct

A nasolacrimal duct and artificial technology, applied in the direction of catheters, devices with human tubular structures, etc., can solve the problems of affecting the treatment effect, leaving scars, and patient pain, so as to achieve good treatment effect, easy removal, and reduce pain.

Active Publication Date: 2014-05-28
广州锐澄医疗技术有限公司
View PDF8 Cites 17 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The advantage of the artificial nasolacrimal duct stent made of degradable materials is that after the human nasolacrimal duct is restored, the artificial nasolacrimal duct stent is completely absorbed, and there is no need to take out the artificial nasolacrimal duct stent again. The degradation process is a body degradation process. During the degradation process, it is prone to collapse, which leads to unsatisfactory repair of the nasolacrimal duct of the human body, affects the treatment effect, and is prone to blockage again; the alternative artificial In the process of removing the nasolacrimal duct stent, a second operation is required, which will not only cause great pain to the patient, but also leave scars

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Artificial nasolacrimal duct
  • Artificial nasolacrimal duct
  • Artificial nasolacrimal duct

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0020] The present invention will be further elaborated below in conjunction with accompanying drawing, wherein, the direction of the present invention is with figure 1 as standard.

[0021] The artificial nasolacrimal duct of the present invention includes an inner tube 1 and a locator, and the locator is arranged on the outer wall of the inner tube 1, and the artificial nasolacrimal duct of the present invention is positioned in the pipeline of the human nasolacrimal duct by utilizing the support of the locator, wherein :

[0022] Such as Figure 5 As shown, the inner tube 1 is made of non-toxic and harmless hard material, generally made of silica gel material, and the outer diameter of the inner tube 1 is slightly smaller than the diameter of the nasolacrimal duct of the human body. The drainage channel 11 that runs through up and down can avoid the entire inner tube 1 from being blocked due to the blockage of one drainage channel 11 . In addition, the inner tube 1 of th...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an artificial nasolacrimal duct which is simple in structure, capable of being led in and led out conveniently, and capable of avoiding repeated operations. The artificial nasolacrimal duct comprises an inner tube which is made of silica gel materials and a locating piece. The locating piece is arranged on the outer wall of the inner tube, and the artificial nasolacrimal duct can be supported by the locating piece to be located in a pipeline of a human body nasolacrimal duct. The inner tube is of a splicing structure of multiple channels and multiple sections. The locating piece either can be a section of spiral band which is made of degradable and expandable materials and arranged on the outer wall of the inner tube or can be an outer pipe which is arranged on the outer wall of the inner tube and made of degradable and expandable materials. The locating piece can further comprise a locating groove and an absorbable line. The spiral locating groove is formed in the outer wall of the inner tube, the absorbable line is wound in the locating groove, the maximum external diameter of the wound absorbable line is slightly larger than the external diameter of the inner tube, so that the absorbable line is in direct contact with the inner wall of the human body nasolacrimal duct, and thus the effect that the artificial nasolacrimal duct is located in the human body nasolacrimal duct through the absorbable line can be achieved.

Description

technical field [0001] The invention relates to an artificial nasolacrimal duct, in particular to an artificial nasolacrimal duct with simple structure, convenient introduction and pouring, and avoiding repeated operations. Background technique [0002] The nasolacrimal duct is the two ducts through which tears flow from the eyes into the nasal cavity. Epiphora is a common and frequently-occurring disease in ophthalmology. It is mainly caused by the obstruction of the nasolacrimal duct. During treatment, it is necessary to implant the Insert or import artificial nasolacrimal duct stents. The current artificial nasolacrimal duct stents are divided into two types, artificial nasolacrimal duct stents made of degradable materials and alternative artificial nasolacrimal duct stents made of silicone materials. The artificial nasolacrimal duct stent made of degradable materials and the alternative artificial nasolacrimal duct stent made of silicone material require a minor operatio...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61F2/04A61M25/00
Inventor 杨习锋曾晨光官习鹏彭芸
Owner 广州锐澄医疗技术有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products